drugset / Trial / NCT00973284

Norwalk Vaccine Study

NCT00973284 ↗

Phase 1/2 Completed 98 enrolled Takeda
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The purpose of this study was to evaluate the efficacy of the Norwalk virus-like particle (VLP) vaccine as determined by the illness rate of viral acute gastroenteritis (AGE) during the inpatient stay.

Timeline

Start
2009-08-04
Primary completion
2010-04-07
Completion
2010-08-18

Drugs

EvaluationDrugModalityDoseRoute
Subject Norwalk VLP Vaccine Vaccine 100 ug Intranasal